Bay Street News, 2024

July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals […]

Lakewood, NJ, July 19, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (NASDAQ: RELI) (“Reliance” or the “Company”), announced today […]

The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical […]

CHENNAI, India, July 19, 2024 (GLOBE NEWSWIRE) — EARNING CALLS DETAILS                   […]

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its […]

SARASOTA, FL, July 19, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage […]

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that […]

LAS VEGAS, NV, July 19, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Golden Matrix Group (NASDAQ: GMGI) (“Golden Matrix” or […]

GREENWICH, Conn., July 19, 2024 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) […]

SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing […]